Company Analysis

Genprex, Inc. (GNPX)

Nasdaq: GNPX · Pharmaceutical Preparations · Austin, TX · filing with the SEC since 2013
Grade4.3
◀ Past 3.4● Present 3.5▶ Future 5.4
5 est.

Filings

387 filings since 2017 beside 99 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Apr 29, 2026.

Filings a yearinsider forms included
4876373751447237
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 10 times in the last 36 months, the newest Aug 5, 2026.Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest Jun 18, 2026.SEC letters: 5 in the last 36 months, the newest Dec 10, 2025.A late-filing notice, Form NT 10-K, filed Apr 1, 2025.
Insider forms 99

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026 8-K items 8.01, 9.01 Other event · Current report
Nov 4, 2026 8-K items 8.01, 9.01 Other event · Current report
Oct 28, 2026 8-K items 8.01, 9.01 Other event · Current report
Oct 21, 2026 8-K items 8.01, 9.01 Other event · Current report
Aug 18, 2026 8-K items 8.01, 9.01 Other event · Current report
Aug 14, 2026 10-Q Quarterly report Jun 30, 2026
Aug 5, 2026 8-K items 3.01, 9.01 Listing warning from its exchange · Current report Aug 4, 2026
Aug 3, 2026 8-K items 8.01, 9.01 Other event · Current report
Jul 30, 2026 8-K items 3.01, 8.01, 9.01 Listing warning from its exchange; Other event · Current report Jul 29, 2026
Jul 14, 2026 8-K items 3.03, 5.03, 7.01, 8.01, 9.01 Change to shareholders' rights; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD); Other event · Current report Jul 13, 2026
Jun 26, 2026 S-8 Employee stock plan registration
Jun 22, 2026 8-K items 8.01, 9.01 Other event · Current report
Jun 18, 2026 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report
Jun 12, 2026 8-K items 3.01, 8.01, 9.01 Listing warning from its exchange; Other event · Current report Jun 10, 2026
Jun 5, 2026 S-3 Shelf registration
May 26, 2026 8-K items 8.01, 9.01 Other event · Current report
May 14, 2026 8-K items 8.01, 9.01 Other event · Current report
May 13, 2026 10-Q Quarterly report Mar 31, 2026
May 11, 2026 SCHEDULE 13G/A Large holder update, amended
Apr 30, 2026 8-K items 8.01, 9.01 Other event · Current report
Apr 29, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 29, 2026 DEF 14A Proxy statement Jun 18, 2026
Apr 28, 2026 8-K items 8.01, 9.01 Other event · Current report
Apr 21, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Apr 17, 2026 PRE 14A Preliminary proxy statement Jun 18, 2026
Mar 30, 2026 10-K Annual report Dec 31, 2025
Mar 18, 2026 8-K items 8.01, 9.01 Other event · Current report
Feb 23, 2026 8-K items 8.01, 9.01 Other event · Current report
Feb 11, 2026 SCHEDULE 13G Large holder notice
Feb 10, 2026 8-K items 8.01, 9.01 Other event · Current report
Jan 9, 2026 8-K items 8.01, 9.01 Other event · Current report Jan 7, 2026
Jan 9, 2026 S-8 Employee stock plan registration
Jan 7, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Jan 6, 2026 8-K items 8.01, 9.01 Other event · Current report
Dec 23, 2025 8-K items 8.01, 9.01 Other event · Current report
Dec 12, 2025 EFFECT Registration effective
Dec 12, 2025 424B3 Shelf offering
Dec 10, 2025 CORRESP Reply to the SEC
Nov 26, 2025 S-1/A Listing registration, amended
Nov 26, 2025 8-K items 3.01, 9.01 Listing warning from its exchange · Current report Nov 25, 2025
40 of 387 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton GNPX · research, not advice